Author: Samuel Garcia del Blanco

Curapath has partnered with Nacalai Tesque to expand access to its portfolio of next-generation polymers and PEG-free shielding lipids for advanced drug delivery applications in Japan. This collaboration strengthens Curapath’s global presence and enables local availability of high-quality excipients for researchers and biopharma companies working on non-viral delivery technologies. Through

Over the past two decades, polymer-based drug delivery systems have evolved from experimental concepts to clinically validated technologies, playing a key role in the development of next-generation therapeutics. At Curapath, with over 13 years of hands-on expertise, we support biotech and pharmaceutical companies with polymer and lipid-based solutions, from early